Literature DB >> 23530516

Ghrelin as a neuroprotective and palliative agent in Alzheimer's and Parkinson's disease.

Vanessa V Dos Santos1, Ana Lúcia S Rodrigues, Thereza C De Lima, Susana R de Barioglio, Rita Raisman-Vozari, Rui D Prediger.   

Abstract

Ghrelin is a gastric hormone that stimulates growth hormone (GH) secretion and food intake to regulate energy homeostasis and body weight by binding to its receptor, GH secretagogue receptor (GHSR1a), which is most highly expressed in the pituitary and hypothalamus. Nowadays there is considerable evidence showing that the GHSR1a is also expressed in numerous extra-hypothalamic neuronal populations and the physiological role of ghrelin is by far wider than considered before including learning and memory, anxiety, depression and neuroprotection. The present review attempts to provide a comprehensive picture of the role of ghrelin in the central nervous system and to highlight recent findings showing its potential as an innovative therapeutic agent in neurodegenerative diseases including Alzheimer's disease and Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23530516     DOI: 10.2174/13816128113199990411

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  13 in total

1.  Ghrelin increases memory consolidation through hippocampal mechanisms dependent on glutamate release and NR2B-subunits of the NMDA receptor.

Authors:  Marisa S Ghersi; L A Gabach; F Buteler; A A Vilcaes; H B Schiöth; M F Perez; S R de Barioglio
Journal:  Psychopharmacology (Berl)       Date:  2014-12-04       Impact factor: 4.530

2.  Older age does not limit postbariatric surgery cognitive benefits: a preliminary investigation.

Authors:  Michael L Alosco; Ronald Cohen; Mary Beth Spitznagel; Gladys Strain; Michael Devlin; Ross D Crosby; James E Mitchell; John Gunstad
Journal:  Surg Obes Relat Dis       Date:  2014-04-18       Impact factor: 4.734

3.  Effect of ghrelin on regulation of splenic sympathetic nerve discharge.

Authors:  Sivasai Balivada; Hitesh N Pawar; Shawnee Montgomery; Michael J Kenney
Journal:  Auton Neurosci       Date:  2016-08-19       Impact factor: 3.145

Review 4.  Microbiome, probiotics and neurodegenerative diseases: deciphering the gut brain axis.

Authors:  Susan Westfall; Nikita Lomis; Imen Kahouli; Si Yuan Dia; Surya Pratap Singh; Satya Prakash
Journal:  Cell Mol Life Sci       Date:  2017-06-22       Impact factor: 9.261

Review 5.  Ghrelin and Neurodegenerative Disorders-a Review.

Authors:  Limin Shi; Xixun Du; Hong Jiang; Junxia Xie
Journal:  Mol Neurobiol       Date:  2016-01-26       Impact factor: 5.590

6.  Ghrelin agonist does not foster insulin resistance but improves cognition in an Alzheimer's disease mouse model.

Authors:  Nicolas Kunath; Thomas van Groen; David B Allison; Ashish Kumar; Monique Dozier-Sharpe; Inga Kadish
Journal:  Sci Rep       Date:  2015-06-19       Impact factor: 4.379

7.  Improved serum leptin and ghrelin following bariatric surgery predict better postoperative cognitive function.

Authors:  Michael L Alosco; Mary Beth Spitznagel; Gladys Strain; Michael Devlin; Ronald Cohen; Ross D Crosby; James E Mitchell; John Gunstad
Journal:  J Clin Neurol       Date:  2015-01-02       Impact factor: 3.077

Review 8.  Preclinical evidence of ghrelin as a therapeutic target in epilepsy.

Authors:  Tongtong Ge; Wei Yang; Jie Fan; Bingjin Li
Journal:  Oncotarget       Date:  2017-06-02

9.  Ghrelin Serum Concentrations Are Associated with Treatment Response During Lithium Augmentation of Antidepressants.

Authors:  Roland Ricken; Sandra Bopp; Peter Schlattmann; Hubertus Himmerich; Tom Bschor; Christoph Richter; Samuel Elstner; Thomas J Stamm; Brigitte Schulz-Ratei; Alexandra Lingesleben; Friedel M Reischies; Philipp Sterzer; Stefan Borgwardt; Michael Bauer; Andreas Heinz; Rainer Hellweg; Undine E Lang; Mazda Adli
Journal:  Int J Neuropsychopharmacol       Date:  2017-09-01       Impact factor: 5.176

10.  Family history of Alzheimer's disease limits improvement in cognitive function after bariatric surgery.

Authors:  Michael L Alosco; Mary Beth Spitznagel; Gladys Strain; Michael Devlin; Ross D Crosby; James E Mitchell; John Gunstad
Journal:  SAGE Open Med       Date:  2014-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.